Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07304193

Clinical and Genetic Aspects of Fetuses With Sex-chromosome Disorders

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
11 Weeks – 22 Weeks
Healthy volunteers
Not accepted

Summary

To conduct a comprehensive clinical investigation of electively aborted fetuses with sex chromosome disorders and their placentas, in parallel with analyses of epigenetic alterations and changes in gene expression in these fetuses and their placentas, with the aims to: 1. delineate how variations in sex chromosome number affect the epigenetic and genetic mechanisms regulating gene expression in the placenta and in multiple fetal tissues in fetuses with sex chromosome disorders; 2. identify the epigenetic and genetic mechanisms and placental and fetal alterations that underlie the phenotypic manifestations observed in fetuses with sex chromosome disorders.

Conditions

Timeline

Start date
2024-01-01
Primary completion
2029-12-31
Completion
2029-12-31
First posted
2025-12-26
Last updated
2026-01-08

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT07304193. Inclusion in this directory is not an endorsement.

Clinical and Genetic Aspects of Fetuses With Sex-chromosome Disorders (NCT07304193) · Clinical Trials Directory